Oxidative Stress, Glutamate, and Neurodegenerative Disorders
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
There is an increasing amount of experimental evidence that oxidative stress is a causal, or at least an ancillary, factor in the neuropathology of several adult neurodegenerative disorders, as well as in stroke, trauma, and seizures. At the same time, excessive or persistent activation of glutamate-gated ion channels may cause neuronal degeneration in these same conditions. Glutamate and related acidic amino acids are thought to be the major excitatory neurotransmitters in brain and may be utilized by 40 percent of the synapses. Thus, two broad mechanisms—oxidative stress and excessive activation of glutamate receptors—are converging and represent sequential as well as interacting processes that provide a final common pathway for cell vulnerability in the brain. The broad distribution in brain of the processes regulating oxidative stress and mediating glutamatergic neurotransmission may explain the wide range of disorders in which both have been implicated. Yet differential expression of components of the processes in particular neuronal systems may account for selective neurodegeneration in certain disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and inflammation are early events of neurodegenerative diseases [920,944-957]”
In the citing paper
“lipid peroxidation could be a major feature of ferroptosis in AD”
In the citing paper
“the brain contains the high levels of polyunsaturated fatty acids (PUFAs) in its membrane rich architecture”
In the citing paper
“The pathophysiology of depression is multifactorial and includes changes in brain monoaminergic transmission (e.g., 5-HT, NE, DA), abnormalities in neurotransmitter receptors function (e.g., AC-cAMP pathway), reduced neurotrophic factors (e.g., BDNF), dysregulation of HPA axis (cortisol), increased proinflammatory cytokines (e.g., IL-6, TNF-α, NF-κB), increased NO (e.g., L-arginine-NO-cGMP pathway”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [45]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Glutamate: A Neurotransmitter in Mammalian Brain
Fonnum, F. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09689.x · Cited by 1,992
Research works printed but not linked: 8
- CHAN, P.H., REDUCED NEUROTOXICITY IN TRANSGENIC MICE OVEREXPRESSING HUMAN COPPER-ZINC SUPEROXIDE-DISMUTASE, STROKE 21: 80 (1990).
- CHOI, D.W., METHODS FOR ANTAGONIZING GLUTAMATE NEUROTOXICITY, CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 2: 105 (1990).
- DICHTER, M, EPILEPSIA 30: S3 (1989).
- HALLIWELL, B, ACTA NEUROLOGICA SCANDINAVICA 80 126: 23 (1989).
- JENNER, P, OXIDATIVE STRESS AS A CAUSE OF PARKINSONS-DISEASE, ACTA NEUROLOGICA SCANDINAVICA 84: 6 (1991).
- Olney, J. W., Kainic Acid as a Tool in Neurobiology: 95 (1978).
- SIESJO, B. K., CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 1: 165 (1989).
- TELLEZ-NAGEL, I, ADVANCES IN NEUROLOGY 1: 387 (1973).
Cited by
Items 501–600 of 1,019
Sengpiel, B., Preis, E., Krieglstein, J., & Prehn, J. H. M. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00202.x · Cited by 144
Calcium signaling alterations, oxidative stress, and autophagy in aging
Ureshino, R. P., Rocha, K. K., Lopes, G. S., Bincoletto, C., & Smaili, S. S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5777 · Cited by 143
“This phenomenon can contribute to cell death that occurs during brain aging (22, 177) and neurodegenerative processes (7, 30, 35).”
Sharma, S., Taliyan, R., & Singh, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.052 · Cited by 142
Singh, P. K., Jain, A., & Kaur, G. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000026067.08356.13 · Cited by 163
“Lipid peroxidation, which is the marker of cellular ROS generation, was significantly increased in different brain regions of both hypoglycemic and diabetic rats when compared to their respective controls (Table 3).”
BackgroundInfluentialThe Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease
Ko, S.-Y., Ko, H.-A., Chu, K.-H., Shieh, T.-M., Chi, T.-C., Chen, H.-I., Chang, W.-C., & Chang, S.-S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143345 · Cited by 139
Liu, D., Ling, X., Wen, J., & Liu, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752144.x · Cited by 153
Timsit, S., Rivera, S., Ouaghi, P., Guischard, F., Tremblay, É., Ben‐Ari, Y., & Khrestchatisky, M. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00434.x · Cited by 140
“It is generally accepted that ischaemic cell death results, at least in part, from glutamate excitotoxicity (Choi, 1988; Coyle & Puttfarcken, 1993).”
BackgroundIs coenzyme Q a key factor in aging?
López‐Lluch, G., Rodríguez‐Aguilera, J. C., Santos‐Ocaña, C., & Navas, P. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.02.003 · Cited by 154
“radical levels found in neurodegenerative diseases (Coyle and Puttfarcken, 1993; Jenner et al., 1992; Olanow, 1993; Schapira et al., 1993) highlights the importance that Q have in these processes.”
BackgroundStefani, A., Spadoni, F., & Bernardi, G. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6554 · Cited by 141
Trial of d-alpha-tocopherol in Huntington's disease
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1771 · Cited by 139
Self-citationSokolovic, D. T., Djindjić, B., Nikolić, J., Bjelaković, G., Pavlovic, D. D., Kocic, G. M., Krstić, D., Cvetković, T., & Pavlović, V. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07077 · Cited by 140
Regulation of Hippocampal Firing by Network Oscillations during Sleep
Miyawaki, H., & Diba, K. (2016) · Current Biology · doi:10.1016/j.cub.2016.02.024 · Cited by 132
“Higher firing and vesicle release also translate into higher metabolic and respiration rates, producing greater oxidative stress, and potentially resulting in cellular damage, accelerated aging, neurodegeneration, and cancer [5, 29–31].”
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease
Wei, H., Qin, Z.-H., Senatorov, V. V., Wei, W., Wang, Y., Qian, Y., & Chuang, D.-M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00311-6 · Cited by 137
Metallothionein-1+2 Protect the CNS after a Focal Brain Injury
Giralt, M., Penkowa, M., Lago, N., Molinero, A., & Hidalgo, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7772 · Cited by 140
Neurophysiological symptoms and aspartame: What is the connection?
Choudhary, A. K., & Lee, Y. Y. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1288340 · Cited by 127
Kim, T. Y., Leem, E., Lee, J. M., & Kim, S. R. (2020) · Antioxidants · doi:10.3390/antiox9070583 · Cited by 149
Maitotoxin and P2Z/P2X7purinergic receptor stimulation activate a common cytolytic pore
Schilling, W. P., Wasylyna, T., Dubyak, G. R., Humphreys, B. D., & Sinkins, W. G. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.4.c766 · Cited by 137
“implicated in excitatory neurotoxicity (5, 7, 37, 38), and”
BackgroundCechetti, F., Worm, P. V., Elsner, V. R., Bertoldi, K., Sanches, E. F., Ben, J., Siqueira, I. R., & Netto, C. A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.09.008 · Cited by 148
Voltage‐Activated Calcium Channels: Targets of Antiepileptic Drug Therapy?
Stefani, A., Spadoni, †., & Bernardi, G. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01477.x · Cited by 138
Atabay, C., Cagnoli, C. M., Kharlamov, E., Ikonomovic, M. D., & Manev, H. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960215)43:4<465::aid-jnr7>3.0.co;2-d · Cited by 139
Song, S., Su, Z., Kon, N., Chu, B., Li, H., Jiang, X., Luo, J., Stockwell, B. R., & Gu, W. (2023) · Genes & Development · doi:10.1101/gad.350211.122 · Cited by 141
“Numerous studies indicate that glutamate-mediated cell death is involved in the pathogenesis of almost all neurological diseases, including Huntington’s diseases (Coyle and Puttfarcken 1993; Caudle and Zhang 2009; Lewerenz and Maher 2015; McGrath et al. 2022).”
Quincozes‐Santos, A., Bobermin, L. D., Latini, A., Wajner, M., Souza, D. O., Gonçalves, C., & Gottfried, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064372 · Cited by 145
“This toxic compound belongs to a family known as reactive nitrogen species or RNS, which cause cellular damage [33,34].”
BackgroundNeuroglobin: From structure to function in health and disease
Ascenzi, P., di Masi, A., Leboffe, L., Fiocchetti, M., Nuzzo, M. T., Brunori, M., & Marino, M. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.10.004 · Cited by 144
Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers
Devi, P. U., Manocha, A., & Vohora, D. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802568230 · Cited by 137
“All three forms of SOD catalyze the dismutation of superoxide anion to hydrogen peroxide, thereby reducing the risk of hydroxyl radical formation [17] .”
BackgroundSpencer, J. P. E., Jenner, A., Butler, J., Aruoma, O. I., Dexter, D. T., Jenner, P., & Halliwell, B. (1996) · Free Radical Research · doi:10.3109/10715769609088005 · Cited by 137
A Review of Fermented Foods with Beneficial Effects on Brain and Cognitive Function
Kim, B., Hong, V. M., Yang, J., Hyun, H., Im, J. J., Hwang, J., Yoon, S., & Kim, J. E. (2016) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2016.21.4.297 · Cited by 128
“Brain structures supporting memory are highly sensitive to oxidative stress partly due to their high demand for oxygen (13).”
BackgroundThe role of transition metals in the pathogenesis of Parkinson's disease
Kienzl, E., Puchinger, L., Jellinger, K. A., Linert, W., Stachelberger, H., & Jameson, R. F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00210-s · Cited by 145
Oxidative Stress, Antioxidants and Neurodegenerative Diseases
Casetta, I., Govoni, V., & Granieri, E. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054065729 · Cited by 147
Excitotoxicity, Oxidative Stress, and the Neuroprotective Potential of Melatonin
Skaper, S. D., Floreani, M., Ceccon, M., Facci, L., & Giusti, P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07985.x · Cited by 136
Lauderback, C. M., Kański, J., Hackett, J. M., Maeda, N., Kindy, M. S., & Butterfield, D. A. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03228-0 · Cited by 149
Chintala, S. K., Zhang, X., Austin, J. S., & Fini, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204824200 · Cited by 140
Kitao, Y., Ozawa, K., Miyazaki, M., Tamatani, M., Kobayashi, T., Yanagi, H., Okabe, M., Ikawa, M., Yamashima, T., Stern, D. M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12978 · Cited by 148
“The cytotoxic effect by excitatory amino acid, which mainly affects neurons (11), suggests that excitatory amino acid acts as a unique environmental stress to neurons and, at the same time, implies that intracellular tools may function in neurons to withstand cellular metabolic crisis.”
Duffy, S. N., & MacVicar, B. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00071.1996 · Cited by 151
“…further augment Ca2+ release from internal stores leading to saturation of [Ca2+li buffering mechanisms and subsequent activation of catabolic processes (i.e., activation of Ca2+-dependent proteases, lipases, and nucleases, and free-radical formation; for review, see Coyle and Puttfarcken, 1993).”
BackgroundBaydas, G., Nedzvetskii, V. S., Tuzcu, M., Yasar, A., & Kirichenko, S. V. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01294-9 · Cited by 135
“In neurodegenerative diseases, oxidative stress both initiates and drives the progression of the pathogenic process (Coyle and Puttfarcken, 1993) and many of the diabetic complications such as diabetic neuropathy are believed to be a result of excessive accumulation of reactive oxygen species and of a decreased antiox…”
BackgroundLi, X. J., Sharp, A. H., Li, S. H., Dawson, T. M., Snyder, S. H., & Ross, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4839 · Cited by 132
Liu, Y. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28873 · Cited by 135
E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures.
Montine, T. J., Amarnath, K., Martin, M. E., Strittmatter, W. J., & Graham, D. G. (1996) · Europe PMC (PubMed Central) · Cited by 156
Le, W., Colom, L. V., Xie, W., SMITH, R. G., Alexianu, M. E., & Appel, S. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00450-5 · Cited by 147
Role of the ubiquitin–proteasome system in brain ischemia: Friend or foe?
Caldeira, M. V., Salazar, I. L., Curcio, M., Canzoniero, L. M. T., & Duarte, C. B. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.003 · Cited by 138
“breakdown of proteins, lipids and nucleic acids, and consequent neuronal death (Coyle and Puttfarcken, 1993; Lee et al., 1999).”
BackgroundFerris, M. J., Mactutus, C. F., & Booze, R. M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.01.004 · Cited by 139
Aliev, G., Smith, M. A., Obrenovich, M. E., de la Torre, J. C., & Perry, G. L. (2003) · Neurotoxicity Research · doi:10.1007/bf03033159 · Cited by 147
“The brain is significantly more vulnerable to ROS-induced damage due to its high rate of oxygen consumption, high polyunsaturated lipid content, and relative weakness of antioxidant systems (Coyle and Puttfarcken, 1993).”
Moskovitz, J., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Jursky, F., Weissbach, H., & Brot, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3205 · Cited by 134
Antioxidant properties of melatonin—an emerging mystery
Beyer, C. E., Steketee, J. D., & Saphier, D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00180-4 · Cited by 134
Topical Review: Glutamate in Neurologic Diseases
Bittigau, P., & Ikonomidou, C. (1997) · Journal of Child Neurology · doi:10.1177/088307389701200802 · Cited by 131
Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants
Han, D., Sen, C. K., Roy, S., Kobayashi, M. S., Tritschler, H. J., & Packer, L. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.5.r1771 · Cited by 135
Antioxidant property of Celastrus paniculatus Willd.: A possible mechanism in enhancing cognition
Kumar, M. H. V., & Gupta, Y. K. (2002) · Phytomedicine · doi:10.1078/0944-7113-00136 · Cited by 133
Tsatmali, M., Walcott, E. C., & Crossin, K. L. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.087 · Cited by 133
Monosodium glutamate-induced oxidative kidney damage and possible mechanisms: a mini-review
Sharma, A. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0192-5 · Cited by 151
“ROS arises as a by-product of aerobic metabolism [45].”
BackgroundNunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W., Tabaton, M., Lee, H.-G., Smith, M. A., Perry, G., & Zhu, X. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318248e614 · Cited by 130
“Indeed, the brain is particularly vulnerable to free radical damage because of its high oxygen consumption rate, abundant lipid content, and relative paucity of antioxidant enzymes compared with other organs (1, 2).”
Gu, X., Sun, J., Li, S., Wu, X., & Li, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.013 · Cited by 145
“The brain consumes much more oxygen compared with other tissues, and it contains less antioxidant enzymes than other organs (Coyle and Puttfarcken, 1993; Floyd and Hensley, 2002).”
BackgroundIkeda, K., Onaka, T., Yamakado, M., Nakai, J., Ishikawa, T., Taketo, M. M., & Kawakami, K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04667.2003 · Cited by 145
“Although the physiological role of spontaneous neural activity in these regions during normal embryonic development is unknown, accumulation of glutamic acid in the extracellular space may induce neural hyperactivity and eventually result in neuronal apoptosis (Choi, 1988; Coyle and Puttfarcken, 1993).”
BackgroundAksenov, M. Y., Tucker, H. M., Nair, P., Aksenova, M. V., Butterfield, D. A., Estus, S., & Markesbery, W. R. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:2:151 · Cited by 139
Duffy, S., So, A., & Murphy, T. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010069.x · Cited by 132
Riccio, A., Mattei, C., Kelsell, R. E., Medhurst, A. D., Calver, A. R., Randall, A. D., Davis, J. B., Benham, C. D., & Pangalos, M. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112313200 · Cited by 146
Miller, S., Romano, C., & Cotman, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06103.1995 · Cited by 133
“If so, it will be important to examine the functional consequences of such a change with regards to the astrocytic response to injury, particularly since disruptions of glutamate homeostasis may be involved in many pathological conditions in the CNS (Coyle and Puttfarcken, 1993; Lipton and Rosenberg, 1994).”
BackgroundInfluentialVogt, M., Bauer, M. K. A., Ferrari, D., & Schulze-Osthoff, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00562-6 · Cited by 130
Ascorbate Inhibits Edema in Brain Slices
Brahma, B., Forman, R. E., Stewart, E. E., Nicholson, C., & Rice, M. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741263.x · Cited by 132
Neuroserpin, a Neuroprotective Factor in Focal Ischemic Stroke
Cinelli, P., Madani, R., Tsuzuki, N., Vallet, P. G., Arras, M., Zhao, C. N., Osterwalder, T., Rülicke, T., & Sonderegger, P. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1028 · Cited by 140
Estrogen Hormones Reduce Lipid Peroxidation in Cells and Tissues of the Central Nervous System
Vedder, H., Anthes, N., Stumm, G., Würz, C., Behl, C., & Krieg, J. ‐. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722531.x · Cited by 134
Eriksson, C., van Dam, A., Lucassen, P. J., Bol, J. G. J. M., Winblad, B. G., & Schultzberg, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00178-5 · Cited by 150
Functional and morphological characteristics of the retinal and choroidal vasculature
Yu, D., Yu, P. K., Cringle, S. J., Kang, M. H., & Su, E. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.02.001 · Cited by 139
“It is well known that the energy demand of the retina is high (Ames et al., 1992; Anderson et al., 1965; Coyle and Puttfarcken, 1993; Yu and Cringle, 2001).”
BackgroundKang, Y., Tiziani, S., Park, G., Kaul, M., & Paternostro, G. (2014) · Nature Communications · doi:10.1038/ncomms4672 · Cited by 127
Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide
Singh, S., & Dikshit, M. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.001 · Cited by 146
Akaike, A., Kaneko, S., Tamura, Y., Nakata, N., Shiomi, H., Ushikabi, F., & Narumiya, S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91268-8 · Cited by 140
Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage
Lin, Y.-R., Chen, H., Ko, C.-H., & Chan, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.035 · Cited by 131
Kim, G. W., Gasche, Y., Grzeschik, S., Copin, J.-C., Maier, C. M., & Chan, P. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08733.2003 · Cited by 132
“The precise mechanism of this degeneration is unknown; however, oxidative stress and mitochondrial dysfunction-linked excitotoxicity have been proposed as key events in the pathophysiology of HD (Albin and Greenamyre, 1992; Coyle and Puttfarcken, 1993; Beal, 1995, 2000).”
Yune, T. Y., Chang, M. J., Kim, S. J., Lee, Y. B., Shin, S. W., Rhim, H., Kim, Y. C., Shin, M. L., Oh, Y. J., Han, C. T., et al. (2003) · Journal of Neurotrauma · doi:10.1089/08977150360547116 · Cited by 145
Lu, Y., Liu, S., Sun, H., Wu, X., Li, J.-J., & Zhu, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.016 · Cited by 138
“It leading to ischemic cell death involves the formation of ROS/RNS through multiple injury mechanisms, such as mitochondrial inhibition, Ca2+ overload, reperfusion injury, and inflammation (Coyle and Puttfarcken, 1993).”
BackgroundThe brain in diabetes: molecular changes in neurons and their implications for end-organ damage
Klein, J. P., & Waxman, S. G. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00503-9 · Cited by 142
Veronesi, B., Makwana, O., Pooler, M., & Chen, L. C. (2005) · Inhalation Toxicology · doi:10.1080/08958370590912888 · Cited by 132
“The presence of OS markers in the CNS tissues of victims with amyotrophic lateral sclerosis, Parkinson’s disease, and Alzheimer’s disease has been reported (Coyle & Puttfarcken,1993; Schulz et al., 2000; Halliwell, 2001; Nunomura et al., 2001; Mattson, 2001).”
BackgroundIncreased susceptibility to MPTP toxicity in middle-aged rhesus monkeys
Ovadia, A., Zhang, Z., & Gash, D. M. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02012-8 · Cited by 143
“Oxidat ive stress, which has been implicated as a ma jo r cont r ibut ing factor to id iopathic h u m a n Park inson i sm (10,13,34), may play a role in the increased M P T P susceptibili ty found in older rhesus.”
Brandoli, C., Sanna, A., De Bernardi, M. A., Follesa, P., Brooker, G., & Mocchetti, I. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07953.1998 · Cited by 131
“…against glutamate-mediated excitotoxicity (Mattson and Scheff, 1994), because glutamate is thought to play an important role in neuronal cell death in a variety of acute and chronic neurodegenerative diseases (Wielock, 1985; Rothman and Olney, 1986; Choi, 1988; Coyle and Puttfarcken, 1993).”
BackgroundCalabresi, P., Centonze, D., Pisani, A., Sancesario, G., Gubellini, P., Marfia, G. A., & Bernardi, G. (1998) · Annals of Neurology · doi:10.1002/ana.410430506 · Cited by 133
“Right: In an LA cholinergic interneuron a positive current step induced three action potentials followed by a firing accommodation and a long-bting after-hyperpolarization (a); in the same cell a step of negative current induced a voltage response that showed a time-dependent decline (6).”
InfluentialAkbaraly, N. T., Faure, H., Gourlet, V., Favier, A., & Berr, C. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.3.308 · Cited by 130
“In fact, the brain is particularly prone to free radical attacks owing to its relatively low antioxidants content, a considerable amount of polyunsaturated fatty acid chains in the neuronal membrane lipids and its high oxygen consumption rate (2).”
BackgroundLiu, L., Rui, L., Gao, Y., & Zhang, W. (2014) · Polymer Chemistry · doi:10.1039/c4py01289e · Cited by 132
Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide
Wei, Z., Bai, O., Richardson, J. S., Mousseau, D. D., & Li, X. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10668 · Cited by 129
“The apoptotic cell death pathway can be activated by oxidative stress (Jacobson, 1996), and this contributes to the neurodegenerative process in Alzheimer’s disease (Subbarao et al., 1990; Coyle and Puttfarcken, 1993; Richardson, 1993; Markesbery, 1997).”
BackgroundVasudeva, R., & Kulkarni, S. K. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00447-0 · Cited by 132
Carrasco, J., Penkowa, M., Hadberg, H., Molinero, A., & Hidalgo, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00128.x · Cited by 130
Duffy, K. B., Spangler, E. L., Devan, B. D., Guo, Z., Bowker, J. L., Janas, A. M., Hagepanos, A., Minor, R. K., de Cabo, R., Mouton, P. R., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.002 · Cited by 148
Nakao, N., Grasbon-Frodl, E. M., Widner, H., Carlson, E. J., Eggerding, F. A., Epstein, C. J., & Brundin, P. (1995) · Nature Medicine · doi:10.1038/nm0395-226 · Cited by 134
In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide
Mayer, B., & Werner, E. R. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171035 · Cited by 140
“thought to contribute to excitotoxicity in the brain (Coyle and Puttfarcken 1993; Lipton et al. 1993).”
BackgroundWang, P., Xie, K., Wang, C., & Bi, J. (2014) · European Neurology · doi:10.1159/000363515 · Cited by 122
Ca2+-Permeable Acid-sensing Ion Channels and Ischemic Brain Injury
Xiong, Z.-G., Chu, X., & Simon, R. P. (2006) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0840-x · Cited by 139
“Over-activation of these enzymes induces breakdown of proteins, lipids and nucleic acids, either directly, or indirectly through downstream signaling molecules (Coyle & Puttfarcken, 1993; Simonian & Coyle, 1996; Lee et al., 1999; Sattler et al., 1999).”
BackgroundCano‐Abad, M. F., Villarroya, M., García, A. G., Gabilan, N. H., & López, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102334200 · Cited by 140
Choi, B., Hur, E., Lee, J.-H., Jun, D., & Kim, K. (2006) · Journal of Cell Science · doi:10.1242/jcs.02837 · Cited by 136
Creatine supplementation lowers brain glutamate levels in Huntington?s disease
Bender, A., Auer, D. P., Merl, T., Reilmann, R., Saemann, P., Yassouridis, A., Bender, J., Weindl, A., Dose, M., Gasser, T., et al. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0595-4 · Cited by 141
“Glu, the main excitatory neurotransmitter, and Gln are closely linked in the Glu-Gln cycle: during neurotransmission, Glu is released into the synaptic cleft, where its levels must be kept low in order to minimize excitotoxicity [13].”
BackgroundHuang, J., & Philbert, M. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00209-9 · Cited by 129
Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons
Kim, S., Ahn, K., Oh, T. H., Nah, S.-Y., & Rhim, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00870-7 · Cited by 128
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Humpel, C. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.032 · Cited by 124
Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status
Martinc, B., Grabnar, I., & Vovk, T. (2015) · Current Neuropharmacology · doi:10.2174/1570159x12666140923205715 · Cited by 125
“Glutamate, which act as excitatory central nervous system (CNS) neurotransmitter and could potentially act excitotoxic, especially at higher concentrations, is believed to be one of the key factors involved in oxidative stress generation [11].”
BackgroundJoubert, J., Foka, G. B., Repsold, B. P., Oliver, D. W., Kapp, E., & Malan, S. F. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.041 · Cited by 132
Natural product coumarins: biological and pharmacological perspectives
Hussain, M. I., Syed, Q. A., Khattak, M. N. K., Hafez, B., Reigosa, M. J., & El‐Keblawy, A. A. (2019) · Biologia · doi:10.2478/s11756-019-00242-x · Cited by 138
Özçankaya, R., & Delibaş, N. (2002) · PubMed · Cited by 128
Bhagwat, S. V., Vijayasarathy, C., Raza, H., Mullick, J., & Avadhani, N. G. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00228-7 · Cited by 128
Vitamin E and neurodegenerative diseases
Ricciarelli, R., Argellati, F., Pronzato, M. A., & Domenicotti, C. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.01.004 · Cited by 140
Formation of free hydroxyl radicals after pentylenetetrazol-induced seizure and kindling
Rauca, C., Zerbe, R., & Jantze, H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02084-3 · Cited by 128
Neuroprotective Role of Dopamine Against Hippocampal Cell Death
Bozzi, Y., Vallone, D., & Borrelli, E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08643.2000 · Cited by 128
“Dysfunctions of glutamatergic neurotransmission are thought to play a key role in the induction of neuronal cell death occurring after brain trauma and in neurological disorders (Choi, 1988; Coyle and Puttfarcken, 1993; Meldrum 1995).”
BackgroundAnalgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain
Kim, H. K., Kim, J. H., Gao, X. M., Zhou, J.-L., Lee, I., Chung, K., & Chung, J. M. (2006) · Pain · doi:10.1016/j.pain.2006.01.013 · Cited by 128
“The most likely sources of oxidants in the cord include superoxides generated from mitochondria and nitric oxides generated by nitric oxide synthase (Coyle and Puttfarcken, 1993; Wu et al., 2001b).”
Backgroundvan Lookeren Campagne, M., Lucassen, P. J., Vermeulen, J. P., & Balazs, R. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01158.x · Cited by 129
“, 1989) and neurodegenerative diseases (Coyle and Puttfarcken, 1993).”
BackgroundHuang, M., Hu, M., Song, Q., Song, H., Huang, J., Gu, X., Wang, X., Chen, J., Kang, T., Feng, X., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03124 · Cited by 127
Metadata
- Authors
- Coyle, J. T., & Puttfarcken, P.
- Affiliations
- Harvard University (US)
- ORCID
- Coyle, Joseph T.
- Venue
- Science
- Published
- 1993-10-29
- Volume
- 262
- Issue
- 5134
- Pages
- 689-695
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2016293448
- Cited by
- 3,762
- References
- 104
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 56 · 2023: 58 · 2022: 51 · 2021: 66 · 2020: 74 · 2019: 83 · 2018: 89 · 2017: 104 · 2016: 105 · 2015: 99 · 2014: 158 · 2013: 126 · 2012: 137
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, glutamate, neurodegenerative diseases, glutamate receptors, excitotoxicity, glutamatergic neurotransmission, neurodegeneration, stroke, traumatic brain injury, seizures, selective neurodegeneration, acidic amino acids
- MeSH terms
- Animals, Brain, Glutamates, Humans, Nervous System Diseases, Reactive Oxygen Species, Receptors, Glutamate, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.